...

Molecular Analysis for Combination Therapy Choice (ComboMATCH) Protocol EAY191-A3, A ComboMATCH Treatment Trial: Palbociclib and Binimetinib in RAS-Mutant Cancers (NCT05554367)

To screen and assign patients to ComboMATCH treatment trials.

Why this Research Matters

To screen and assign patients to ComboMATCH treatment trials.

Who can Participate

Adult

Detailed eligibility criteria is available on ClinicalTrials.gov. These requirements will be discussed with your doctor and/or study representative. Visit ClinicalTrials.gov to learn more about this study.

Study ID

Protocol Number: 24-0233
More information available at ClinicalTrials.gov: NCT05554367

Meet the Team

Image of Principal Investigator

Robert Lentz, MD

Principal Investigator

Categories

Locations